ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects

Obstet Gynecol. 2008 Sep;112(3):727-30. doi: 10.1097/AOG.0b013e318188d1ec.
No abstract available

MeSH terms

  • Bone Density / drug effects*
  • Contraceptive Agents, Female / adverse effects*
  • Drug Approval
  • Female
  • Fractures, Bone / chemically induced
  • Humans
  • Medroxyprogesterone Acetate / adverse effects*
  • Osteoporosis / chemically induced*
  • Time Factors

Substances

  • Contraceptive Agents, Female
  • Medroxyprogesterone Acetate